Stanford Letter or Traditional Advance Directive in Advance Care Planning in Patients Undergoing Bone Marrow Transplant
Trial ID or NCT#
Status
Purpose
The purpose of the proposed research study is to evaluate whether bone marrow transplant patients prefer the Stanford letter advance care planning tool to the standard Advance directive. Completion of advance care planning prior to BMT is very important, but not often done. The investigators believe that the Stanford Letter will be preferred by patients and will allow them to feel more comfortable and share more of their wishes with family members and the medical team.
Official Title
Randomized Clinical Study Comparing the Effectiveness of the Stanford Letter to the Traditional Advance Directive in Bone Marrow Transplant Recipients
Eligibility Criteria
- - All BMT patients at Stanford who are adults and give consent
- - Less than 18 years of age
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
VJ PERIYAKOIL, MD
650-493-5000
View on ClinicalTrials.gov